Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000940180-99-001549
Filing Date
1999-12-14
Accepted
1999-12-14 00:00:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 36010
2 FORM OF VOTING AGREEMENT DATED 11/99. EX-1 40429
3 LETTER AGREEMENT DATED 11/26/99. EX-2 4369
4 AGREEMENT AND PLAN OF MERGER DATED 11/26/99. EX-3 266064
5 FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION. EX-4 10345
6 FORM OF AMENDED AND RESTATED BY-LAWS EX-5 56508
  Complete submission text file 0000940180-99-001549.txt   416138
Mailing Address
Business Address 1333 CAMPUS PARKWAY NEPTUNE NJ 07753 9089385959
ALGOS PHARMACEUTICAL CORP (Subject) CIK: 0000924862 (see all company filings)

EIN.: 223142274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48097 | Film No.: 99774379
SIC: 2834 Pharmaceutical Preparations

Mailing Address 223 WILMINGTON-WEST CHESTER PIKE CHADDS FORD PA 19317
Business Address 223 WILMINGTON-WEST CHESTER PIKE CHADDS FORD PA 19317 6105589800
ENDO PHARMACEUTICALS HOLDINGS INC (Filed by) CIK: 0001100962 (see all company filings)

EIN.: 134022871 | State of Incorp.: DE | Fiscal Year End: 1231